Om avsnittet
Hosted by Horizon 3 Biotech Chief Investment Officer Matt McNamara In this episode Matt will be joined by Dirk van Dissel of Candour Advisory and Chris Baldwin, Deputy CEO and Chief Commercial Officer of Exopharm.
Senaste avsnitten
Investing in Biotech from Horizon 3 Biotech
Investing in Biotech
2022-06-22 • 37min
Investing in Biotech from Horizon 3 Biotech
Investing in Biotech
2022-06-01 • 1h 2min
Investing in Biotech from Horizon 3 Biotech
Investing in Biotech
2022-03-21 • 49min
Investing in Biotech from Horizon 3 Biotech
Investing in Biotech
2022-02-10 • 34min
Investing in Biotech from Horizon 3 Biotech
Investing in Biotech
2021-12-22 • 31min
Investing in Biotech from Horizon 3 Biotech
Investing in Biotech
2021-11-08 • 42min
Investing in Biotech from Horizon 3 Biotech
Investing in Biotech
2021-10-26 • 35min
Investing in Biotech from Horizon 3 Biotech
BioBullets: The Great Dispersion
2021-09-17 • 13min
Investing in Biotech from Horizon 3 Biotech
Investing in Biotech
2021-09-13 • 37min
Investing in Biotech from Horizon 3 Biotech
BioBullets: The Aduhelm FDA approval controversy
2021-08-13 • 10min